Accelerating Innovation at Leica Biosystems

Aldevron Overview ~$400M TOTAL REVENUE 2021E Revenue By Mix Plasmids -90% >20% ANTICIPATED LONG-TERM CORE REVENUE GROWTH Total revenue and core growth are anticipated financial results; pie charts represent % of 2020 total revenue By Geography US >90% aldevron Leading producer of high-quality plasmid DNA, mRNA and proteins • • Terrific brand with long-term sustainable growth model Scale, quality, reputation, turnaround time and know-how provide differentiated benefit to customers DBS opportunities to further enhance high-performing business Fast-growing, highly attractive genomic medicine space Accelerating adoption of gene & cell therapies, DNA and RNA vaccines, and gene editing technologies Expect Aldevron to be accretive on multiple levels DANAHER

View entire presentation